Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / By country / Poland

Peptide legality · Poland · updated 2026-09-22

Are peptides legal in Poland?

Restricted

Peptides are restricted in Poland: approved peptide medicines (such as semaglutide, tirzepatide and somatropin/HGH) are legal only as prescription-only medicines dispensed through pharmacies, while unapproved 'research' peptides like BPC-157 and TB-500 have no marketing authorisation and cannot be lawfully sold or supplied for human use.

Legal status overview

Peptides are restricted in Poland rather than freely legal or blanket-banned. Poland has no peptide-specific statute; instead peptides are governed by the general Pharmaceutical Law (Prawo Farmaceutyczne, Act of 6 September 2001), which transposes EU Directive 2001/83/EC and treats any substance presented for treating disease or modifying physiological functions as a medicinal product requiring authorisation. The Główny Inspektor Farmaceutyczny (GIF) is the primary pharmaceutical regulator and the URPL handles marketing authorisations, so approved peptide drugs are prescription-only while unapproved research peptides fall outside any lawful human-use retail channel.

Key points

  • Peptides are restricted in Poland under the general Pharmaceutical Law (Prawo Farmaceutyczne, Act of 6 September 2001) rather than under any peptide-specific statute. [1]
  • Poland's Pharmaceutical Law transposes EU Directive 2001/83/EC and, under its Article 2 definition, treats any substance presented as treating or preventing disease or modifying physiological functions in humans as a medicinal product requiring authorisation. [2]
  • The Główny Inspektor Farmaceutyczny (GIF) is Poland's primary pharmaceutical regulator, while the URPL handles marketing-authorisation applications for medicinal products including peptide drugs. [2]
  • Poland's Pharmaceutical Law of 6 September 2001 sorts medicinal products into five availability categories (OTC, prescription 'Rp', restricted prescription 'Rpz', narcotic/psychotropic prescription 'Rpw', and hospital-only 'Lz'), so an authorised peptide medicine is dispensed according to its assigned category. [4]
  • Approved peptide medicines such as semaglutide, tirzepatide and somatropin/HGH are legal in Poland only as prescription-only medicines regulated under EU/EMA pharmaceutical rules. [3]
  • Unapproved research peptides such as BPC-157 have no EU or Polish marketing authorisation, so there is no lawful prescription or over-the-counter retail channel for them for human use in Poland. [3]
  • For personal import into Poland, a traveller may generally carry a personal supply of a legitimately prescribed peptide medicine, but mail-ordering unapproved research peptides risks customs seizure and possible consequences under national pharmacy law. [3]
  • Peptides are not listed as controlled substances under Poland's narcotics legislation, so their restriction flows from medicines law rather than drug-scheduling law. [2]

Compound-by-compound status

BPC-157BPC-157 is an unapproved research peptide in Poland with no EU or Polish marketing authorisation, meaning it cannot be lawfully sold or supplied for human use and circulates only as a labelled 'research chemical'. [3]
Semaglutide (GLP-1, e.g. Ozempic®/Wegovy®)Semaglutide is legal in Poland but only as an EMA-approved, prescription-only medicine dispensed through pharmacies, not as an over-the-counter or research product. [3]
TB-500 (Thymosin beta-4)TB-500 is an unapproved research peptide in Poland with no EU or Polish marketing authorisation, so like BPC-157 it has no lawful human-use retail channel. [3]
HGH / somatropinHuman growth hormone (somatropin/HGH) is legal in Poland only as an approved prescription-only medicine, and unapproved HGH-related peptides sold as research chemicals fall outside any lawful supply channel. [3]

Frequently asked questions

Can I buy peptides in Poland without a prescription?

No, approved peptide medicines in Poland (like semaglutide and HGH) are prescription-only, and unapproved research peptides such as BPC-157 have no marketing authorisation and cannot be lawfully sold for human use, so there is no legal over-the-counter peptide channel. [3]

Can I order or bring peptides into Poland for personal use?

You may generally carry a personal supply of a legitimately prescribed peptide medicine into Poland, but mail-ordering unapproved research peptides such as BPC-157 or TB-500 risks customs seizure and possible consequences under Polish pharmacy law. [3]

Is BPC-157 legal in Poland?

BPC-157 is not legal for human use in Poland: it has no EU or Polish marketing authorisation, so it cannot be prescribed, sold in pharmacies, or lawfully supplied as a medicine and exists only as a 'research chemical'. [3]

Is Ozempic®/semaglutide legal in Poland?

Yes, semaglutide (Ozempic®/Wegovy®) is legal in Poland as an EMA-approved, prescription-only medicine, meaning it must be prescribed by a licensed prescriber and dispensed through a pharmacy. [3]

Are peptides classed as controlled/narcotic substances in Poland?

No, peptides are not listed as controlled substances under Poland's narcotics legislation; their legal restriction comes from the Pharmaceutical Law (medicines law) rather than from drug-scheduling law. [2]

General information based on the sourced research above, not legal advice. Laws change and enforcement varies; for a specific situation in Poland, consult a licensed attorney or the national regulator.